Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease

BACKGROUND: Thiopurines remain recommended as maintenance therapy in patients with inflammatory bowel disease (IBD). Despite their widespread use, long‐term effectiveness data are sparse and safety is an increasingly debated topic which thwarts proper delineation in the current IBD treatment algorit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezazadeh Ardabili, Ashkan, Jeuring, Steven, Mujagic, Zlatan, Oostenbrug, Liekele, Romberg‐Camps, Mariëlle, Jonkers, Daisy, van Bodegraven, Adriaan, Pierik, Marieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Thiopurine Monotherapy in IBD
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544244/
https://www.ncbi.nlm.nih.gov/pubmed/35794735
http://dx.doi.org/10.1111/apt.17128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544244/
https://www.ncbi.nlm.nih.gov/pubmed/35794735
http://dx.doi.org/10.1111/apt.17128

Ejemplares similares